clinical study insights

Comparative Data Favor Interleukin-6 Receptor Inhibitor Monotherapy
Rheumatology

Comparative Data Favor Interleukin-6 Receptor Inhibitor Monotherapy

clinical study insights
By Daniel E. Furst, MD
Epstein-Barr Virus Associated With Greater Multiple Sclerosis Susceptibility Among Whites, Blacks, and Hispanics
Neurology

Epstein-Barr Virus Associated With Greater Multiple Sclerosis Susceptibility Among Whites, Blacks, and Hispanics

clinical study insights
By Aaron Miller, MD
Clinically Meaningful Improvement in Patient-Reported Outcomes With Interleukin-6 Inhibition
Rheumatology

Clinically Meaningful Improvement in Patient-Reported Outcomes With Interleukin-6 Inhibition

clinical study insights
By Daniel E. Furst, MD
Questions Surrounding Early Use of Ocrelizumab in Patients With Relapsing Multiple Sclerosis
Neurology

Questions Surrounding Early Use of Ocrelizumab in Patients With Relapsing Multiple Sclerosis

clinical study insights
By David A. Hafler, MD
Load More